Skip to main content
Home / Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 26, Number 9

Open Access [ARTICLE WITHDRAWN] MicroRNA-18a Targets IRF2 and CBX7 to Promote Cell Proliferation in Hepatocellular Carcinoma

Notice

This article has been taken down at the request of the publisher.

Please contact the publisher for further information.

THIS ARTICLE WAS WITHDRAWN BY THE PUBLISHER IN NOVEMBER 2020.

Keywords: Chromobox protein homolog 7 (CBX7); Hepatocellular carcinoma (HCC); Interferon regulatory factor 2 (IRF2); Migration; Proliferation; miR-18a

Document Type: Research Article

Affiliations: 1: Department of Interventional Radiology, the Fifth Affiliated Hospital of Sun Yat-sen University, Xiangzhou District, Zhuhai, P.R. China 2: Department of Radiation Oncology, the Fifth Affiliated Hospital of Sun Yat-sen University, Xiangzhou District, Zhuhai, P.R. China 3: Department of Infectious Diseases, the Fifth Affiliated Hospital of Sun Yat-sen University, Xiangzhou District, Zhuhai, P.R. China 4: Department of Nursing, the Fifth Affiliated Hospital of Sun Yat-sen University, Xiangzhou District, Zhuhai, P.R. China

Publication date: 17 October 2018

More about this publication?

  • Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
    Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

    From Volume 23, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics is Open Access under the terms of the Creative Commons CC BY-NC-ND license.

  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Ingenta Connect is not responsible for the content or availability of external websites

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content